| December 13, 2013, Friday - Day 1 |
| The 3rd ASGO Opening: Luncheon Symposium: Eradication of Cervical Cancer from Earth: Global Approach |
Cancer prevention through HPV vaccination in developing countries.  |
Lynette A. Denny |
| Cancer screening via HPV testing and/or cytology. |
Murat Gultekin |
| Management of high grade cervical lesions and microinvasive cancer. |
Vesna Kesic |
| The 3rd ASGO Opening Plenary: Welcome from Japan |
| Presidential Lecture: Asian Society of Gynecologic Oncology: Whoweare, where We are going? |
Toshiharu Kamura |
| Invited Lecture: Mission of Federation of Asian Clinical Oncology(FACO). |
Masahiko Nishiyama |
| Educational Lecture :Toward individualization of radiation therapy by physical approach. |
Masahiro Hiraoka |
| Special Lecture : Genome-based tailoring for cancer therapy: A lesson from lung cancer. |
Hiroyuki Mano |
| The 3rd ASGO Evening Symposium (1) - Treatment of Advanced: Recurrent Ovarian Cancer: Future Perspective |
| Improving survival in women with ovarian cancer: Future directions. |
David M. Gershenson |
| Best combination of drugs for first second-line chemotherapy. |
Seiji Isonishi |
| Neoadjuvant chemotherapy in advanced ovarian cancer. |
Keiichi Fujiwara |
| How to select and perform surgery for recurrent ovarian cancer. |
Sang Yoon Park |
| Chemotherapy and best supportive care for recurrent patients. |
Chih-Long Chang |
| Roadmap for tailored medicine inovarian cancer treatment. |
David G. Huntsman |
| The 3rd ASGO Morning Lecture (1) - Treatment of Advanced Cervical Cancer: Update |
| Concurrent chemoradio therapy (CCRT) for locally advanced cervical cancer: What is next? |
Takafumi Toita |
| Chemotherapy for cervical cancer : Neoadjuvant and adjuvant setting. |
Nobuhiro Takeshima |
| Educational Lectureon Ovarian Cancer |
| Screening and early detection of ovarian cancer : Is it feasible? |
Barbara Goff |
| Fertility-sparing treatment for early ovarian cancer. |
Jeong-Won Lee |
| Treatment of platinum-resistant ovarian cancer. |
Koji Matsumoto |
| Updates on the management of advanced metastatic ovarian cancer. |
Lim Sheow Lei |
| Psychological support for patients with ovarian cancer. |
Vesna Kesic |
| Educational Lectureon Endometrial Cancer |
| Role of metabolic syndrome in endometrial cancer and its precancerous diseases. |
Xiaojun Chen |
| Pathology of endometrial cancer and its precursor. |
Annie NY Cheun |
| Atypical polypoid adenomyoma : Precursor of cancer? |
Tsunehisa Kaku |
| Treatment of high-intermediate risk endometrial cancer patients. |
Linus Chuang |
| Standard treatment of uterine carcinosarcoma(update). |
Chi-Heum Cho |
| The 3rd ASGO Luncheon Symposium (1) - Treatment of Stage IIB Cervical Cancer |
| Concurrent chemoradio therapy (CCRT) for Stage IIB disease: Where are we now? |
Kailash Narayan |
| Role of radical surgery instage IIB disease Treatment of Stage IIB disease. |
Mikio Mikami |
| The 3rd ASGO Asia-Oceania Symposium - Current Statuson Cervical Cancer in Our Country |
| Preventing cervical cancer in Australia: Still a little way to go. |
Michael A. Quin |
| Overview on cervical cancer control and prevention in Asian countries. |
Hextan YS Nga |
| How can we overcome adverse reactions in HPV vaccination in Japan? |
Etsuko Miyagi |
| Cervical cancer control in India: Strategy in urban vs rural areas. |
Neerja Bhatla |
| Current status of cervical cancer control in Thailand: Which screening method is best? |
Wisit Supakarapongkul |
| Cervical cancer control in multinational society: Challenge in Singapore. |
Sun Kuie Tay |
| The decreasing trend in cervical cancer in Taiwan: What is next? |
Choyng-Huey Lai |
| The 3rd ASGO Evening Symposium (2) - Molecular-Targeted Therapy for Gynecological Canceris Coming Soon |
| Molecular-targeted therapy in gynecologic oncology: Overview. |
Nicoletta Colombo |
| Anti-angiogenes is therapy for ovarian cancer: Moving beyond VEGF. |
Anil K. Sood |
| Perspective on molecular targeted therapy for endometrial cancer. |
Katsutoshi Oda |
| Is molecular-targeted therapy effective for uterine sarcomas? |
Chi-Mu Chuang |
| Selection of drugs against ovarian cancer based on gene expression profile. |
Noriomi Matsumura |
| Development of novel therapy for gynecological cancer. |
Jae-Hoon Kim |
| December 14, 2013, Saturday - Day 2 |
| The 3rd ASGO Morning Lecture (2) - Ovarian Clear Cell Carcinoma: Update |
| Clinical and molecular features of ovarian clearcell carcinoma. |
Kentaro Nakayama |
| Moleculargenetics of ovarian clear cell carcinoma. |
David G. Huntsman |
| Workshop on Ovarian Cancer |
| Active genetic counseling with immunohistochemistry can elevate detection rate of BRCA mutation among ovarian carcinoma patients. |
Min Kyu Kim |
| Evaluation of Risk of Malignancy Index as atriage tool for ovarian cancer. |
Gregorius Tanamas |
| Comparison of CA-125,ultrasound, menopausal status and Risk of Malignancy Index(RMI)in pre-operative diagnosis of ovarian tumors. |
Arun Muthuvel Veluswamy |
| The management of peritoneal surface malignancies at the American University of Beirut Medical Center: Initial experience. |
Muhieddine AF Seoud |
| Disseminated endometroid adenocarcinoma of ovary in a 14 year old girl: A case report. |
Himali, P Ihalagama |
| Additional intraperitonealcisplatin/etoposide to first-line chemotherapy in advanced epithelial ovarian cancer: Interim analysis of a randomized phase II study. |
Rong Jiang |
| Pazopanib maintenance therapy in East Asian (EA) women with advanced epithelialovarian cancer (AEOC): Results of two clinical trials. |
Jae-Weon Kim |
| Clinicopathologic characteristics in patients with synchronous primary endometrial andovarian cancers: A review of 43 cases. |
Yuantao Liu |
| Comparison of survival out come between clear cell and non-clear cell types of epithelial ovarian cancer instage IA and IB. |
Yu-Jin Koo |
| Primary treatment and prognostic factors of carcinosarcoma of ovary, fallopian tube, and peritoneum: A Taiwanese Gynecologic Oncology Group study. |
Chien-Hsing Lu |
| Workshop on Endometrial Cancer |
| Diagnostic value of the conventional and liquid-based endometrial cytology in endometrial cancer. |
Yuko Sugiyama |
| Significance of endometrial cells in cervical cytology. |
Eun Jeong Yu |
| Usefulness of transcervical tumor resection in diagnosing myometrial invasion for young patients with endometrial cancer who received fertility-preserving progesterone therapy. |
Nobuyuki Susumu |
| Endometrial cancer risk of recurrence and post operative histopathological findings. |
Jasmine Iskandar |
| Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer: Long-term results at a single institution. |
Min-Hyun Baek |
| Analysis of prognostic parameter in endometrial cancer: Obesity as aprognostic indicator in endometrial cancer. |
Ranka Kanda |
| Pure uterine papillary serous cancer: Evaluation of survival and managements: A Taiwanese Gynecologic Oncology Group (TGOG) study. |
Chia-Yen Huang |
| Longterm survival analysis of clear cell type endometrial cancer: A retrospective multi-center study by Taiwanese Gynecologic Oncology Group (TGOG). |
Keng-fu Hsu |
| Raloxifene hydrochloride improves health care problems of patients who underwent surgeries for endometrial cancer: A multicenter clinical trial. |
Koji Nakamura |
| Efficacy of methotrexate chemoprophylaxis in preventing postmolar gestational trophoblastic disease among patients with high-risk hydatidiform mole: A randomized controlled trial. |
Jimmy A. Billod |
| The 3rd ASGO Luncheon Symposium (2) - Diagnosisand Treatment of Uterine Sarcomas. |
| An update on the pathology of uterine sarcomas. |
Charles Zaloudek |
| Clinical diagnosis and treatment for uterine sarcomas. |
Yoshio Yoshida |
| Round Table Discussion for Serous Ovarian Cancer (SOC). |
| Tubal origin of high-grade serous carcinoma: Do you believe? |
Steven G. Silverberg |
| What have we learned from The Cancer Genome Atlas. |
Anil K. Sood |
| Molecular mechanism for peritoneal dissemination of serous ovarian cancer. |
Chul Min Lee |
| Pathology of border line serous tumors and lowgrade serous ovarian cancer. |
Charles Zaloudek |
| Imaging diagnosis of low-grade SOC and serous border line tumor. |
Kaori Togashi |
| Contemporary management of low-grade serous ovarian cancer. |
David M. Gershenson |
| Round Table Discussion for High-Risk Endometrial Cancer. |
| Imaging of myometrial invasion of endometrial cancer. |
Dong Hoon Suh |
| "MELF pattern" of myoinvasion of low-grade endometrial adenocarcinoma. |
Yoshiki Mikami |
| How to manage endometrial cancer with deep myometrial invasion? |
Hidemichi Watari |
| Uterine serous papillarycarcinoma: Pathology and molecular aspects. |
Ayse Ayhan |
| Clinical management of uterine serous papillary carcinoma. |
John Chia Whay Kuang |
| Treatment of Stage IV Bendometrial cancer: A retrospective multi-institutional study of 426 patients in Japan. |
Takako Eto |
| The 3rd ASGO Luncheon Symposium (3) - Era of HPV DNA Testing for Cervical Cancer Screening |
| The importance of HPV-16/18 genotyping in ASCUS and cervical cancer screening. |
Sun Kuie Tay |
| The role of HPV tests in cervical cancer screening in Japan and Asia. |
Ryo Konno |
| Palliative Care for Women with Gynecological Cancer * Someparts in Japanese |
| Pain management in women with advanced cervical cancer. |
Lynette A. Denny |
| Assessment of quality of life in palliative care for women with gynecologic cancer. |
Akiko Sukegawa |
| Investigation of the prevalence of neuropathic pain in gynecologic cancer patientsand efficacy and safety of oxycodone for pain management (INGYCO) study in Japan. |
Akiko Tozawa |
| Management of Malignant Ascites in Gynecological Cancer |
| Intraperitoneal chemotherapy inepithelial ovarian cancer. |
Shoji Nagao |
| Efficacy and safety of CART (cell-free and concentrated ascites reinfusion therapy) in gynecological cancer patients. |
Yasuhisa Terao |
| December 15, 2013,Sunday - Day 3 |
| The 3rd ASGO Morning Lecture (3) - Laparoscopic Surgery for Gynecological Cancer |
| Role of laparoscopy in cervical cancer surgery. |
Hiroyuki Kanao |
| Laparoscopic surgery for endometrial cancer. |
Kung-Liahng Wang |
| Educational Lectureon Gynecologic Cancer Surgery (1) |
| How to be less radical in early stage cervical cancer. |
Michael A. Quinn |
| Radical hysterectomy for cervical cancer in Thailand. |
Jatupol Srisomboon |
| Nerve-sparing radical hysterectomy in the treatment of early cervical cancer. |
Dae-Yeon Kim |
| Radical trachelectomy for early stage cervical cancer. |
Chi-An Chen |
| Surgery following neoadjuvant chemotherapy (NAC) for cervical cancer. |
Chunling Chen |
| Educational Lectureon Gynecologic Cancer Surgery (2) |
| Cytoreductive surgery for advanced ovarian cancer. |
Suk-Joon Chang |
| Pelvic & paraortic lymphadenectomy in ovarian cancer. |
Suresh Kumarasamy |
| Peritoneal stripping in ovarian cancer surgery. |
Ting-Chang Chang |
| Surgery after neoadjuvant chemotherapy in ovarianc ancer. |
Kazuyoshi Kato |
| Surgery and chemotherapy in germ cell tumor of ovarian cancer. |
Laila Nuranna |
| The 3rd ASGO Luncheon Symposium (4) - Robotoic Surgery for Cervical Cancer |
| Robotic radical hysterectomy: Principle and practice. |
Angelo Maggioni |
| Robotic radical hysterectomy: Training for beginners. |
Masaki Mandai |
| Educational Lectureon Gynecologic Cancer Surgery (3) |
| Abdominal radical trachelectomy from our ten year's experience. |
Takuma Fujii |
| Robotic radical trachelectomy in Korea. |
Jae Kwan Lee |
| Sentinel node detection in radical trachelectomy. |
Hiroaki Kobayashi |
| The 3rd ASGO Morning Lecture (4) - Gestational Trophoblastic Disease: Update |
| Clinical manifestations of early stage hydatidiform mole. |
Takashi Ohba |
| Chemotherapy for high-risk trophoblastic neoplasm. |
Elizabeth K. Jacinto |
| The 3rd ASGO Luncheon Symposium (5) - Laparoscopic Lymphadenectomy for Gynecological Cancer |
| Pelvic lymph adenectomy for endometrial cancer. |
Yoshito Terai |
| Laparoscopic paraaortic lymphadenectomy. |
Hiroshi Funamoto |
